Varex Imaging (NASDAQ:VREX) Posts Earnings Results, Beats Estimates By $0.05 EPS

Varex Imaging (NASDAQ:VREX) issued its quarterly earnings results on Tuesday. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.05, FiscalAI reports. The firm had revenue of $209.60 million during the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.

Varex Imaging Price Performance

Shares of NASDAQ:VREX traded up $0.11 on Tuesday, hitting $14.15. The company had a trading volume of 512,771 shares, compared to its average volume of 330,204. The company has a current ratio of 3.43, a quick ratio of 1.83 and a debt-to-equity ratio of 0.75. The company has a market cap of $593.17 million, a PE ratio of -8.32 and a beta of 0.90. The business has a 50 day moving average of $12.79 and a 200 day moving average of $11.70. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $14.56.

Institutional Trading of Varex Imaging

Several institutional investors have recently made changes to their positions in VREX. Brooklyn Investment Group increased its position in shares of Varex Imaging by 51.3% in the third quarter. Brooklyn Investment Group now owns 17,511 shares of the company’s stock worth $217,000 after acquiring an additional 5,934 shares in the last quarter. Glenmede Investment Management LP acquired a new stake in shares of Varex Imaging in the 3rd quarter valued at about $153,000. BNP Paribas Financial Markets grew its position in shares of Varex Imaging by 37.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 17,901 shares of the company’s stock worth $222,000 after acquiring an additional 4,856 shares in the last quarter. Mackenzie Financial Corp acquired a new position in shares of Varex Imaging in the 3rd quarter valued at about $228,000. Finally, Brevan Howard Capital Management LP bought a new position in Varex Imaging during the 2nd quarter worth $218,000.

Analyst Upgrades and Downgrades

Several research firms have issued reports on VREX. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a report on Monday, February 2nd. Oppenheimer reduced their price objective on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. Finally, B. Riley Financial reiterated a “buy” rating and issued a $16.00 price target on shares of Varex Imaging in a research note on Wednesday, November 19th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Varex Imaging has a consensus rating of “Hold” and an average target price of $16.17.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.